Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients

J Thromb Haemost. 2003 Jan;1(1):186-7. doi: 10.1046/j.1538-7836.2003.00005.x.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Ambulatory Care / standards*
  • Anticoagulants / therapeutic use
  • Feasibility Studies
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Middle Aged
  • Nadroparin / therapeutic use
  • Outpatients*
  • Phenprocoumon / therapeutic use
  • Pulmonary Embolism / drug therapy*
  • Pulmonary Embolism / epidemiology
  • Risk
  • Treatment Outcome

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Nadroparin
  • Phenprocoumon